Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome

Clinical Nutrition

Volumn 34, Issue 4, 2015, Pages 586-592

  Asemi, Zatollah ^a   Foroozanfard, Fatemeh ^a   Hashemi, Teibeh ^a   Bahmani, Fereshteh ^a   Jamilian, Mehri ^b   Esmaillzadeh, Ahmad ^c,d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; Glucose metabolism; Lipid concentrations; Polycystic ovary syndrome; Supplementation; Vitamin D

Indexed keywords

CALCIUM; COLECALCIFEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D; CALCIUM INTAKE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; ADOLESCENT; BLOOD; BODY MASS; CALCIUM INTAKE; CALORIC INTAKE; CARBOHYDRATE METABOLISM; DIETARY SUPPLEMENT; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; METABOLISM; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CALCIUM, DIETARY; CARBOHYDRATE METABOLISM; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENERGY INTAKE; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84930760422     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.09.015     Document Type: Article

References (30)

1. Shen W., Zhang Y., Li W., Cong J., Zhou Y., Ng E.H., et al. Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial. BMJ Open 2013, 3:e003646. 10.1136/bmjopen-2013-003646.
2. Sirmans S.M., Pate K.A. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013, 6:1-13. 10.2147/CLEP.S37559.
3. Mehrabian F., Khani B., Kelishadi R., Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011, 62:238-242.
4. Murri M., Insenser M., Escobar-Morreale H. Metabolomics in polycystic ovary syndrome. Clin Chim Acta 2014, 429:181-188.
5. Rajendran S., Willoughby S.R., Chan W.P., Liberts E.A., Heresztyn T., Saha M., et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis 2009, 204:509-514.
6. Wild R.A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H.F., Futterweit W., et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) Society. JClin Endocrinol Metab 2010, 95:2038-2049.
7. Lerchbaum E., Schwetz V., Giuliani A., Obermayer-Pietsch B. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women. Eur J Endocrinol 2014, 170:727-739.
8. Mazloomi S., Sharifi F., Hajihosseini R., Kalantari S., Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012, 2012:949427. 10.5402/2012/949427.
9. Firouzabadi R., Aflatoonian A., Modarresi S., Sekhavat L., MohammadTaheri S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract 2012, 18:85-88.
10. Pal L., Berry A., Coraluzzi L., Kustan E., Danton C., Shaw J., et al. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 2012, 28:965-968.
11. Wehr E., Pieber T.R., Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. JEndocrinol Invest 2011, 34:757-763.
12. Nair-Shalliker V., Armstrong B.K., Fenech M. Does vitamin D protect against DNA damage?. Mutat Res 2012, 733:50-57.
13. Aloia J.F., Dhaliwal R., Shieh A., Mikhail M., Islam S., Yeh J.K. Calcium and vitamin D supplementation in postmenopausal women. JClin Endocrinol Metab 2013, 98:E1702-E1709.
14. Wehmeier K., Beers A., Haas M.J., Wong N.C., Steinmeyer A., Zugel U., et al. Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta 2005, 1737:16-26.
15. Zhu W., Cai D., Wang Y., Lin N., Hu Q., Qi Y., et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutr J 2013, 12:8. 10.1186/1475-2891-12-8.
16. Saneei P.S.-A.A., Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 2013, 14:393-404.
17. Tsakova A.D., Gateva A.T., Kamenov Z.A. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity. Int J Vitam Nutr Res 2012, 82:399-404.
18. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
19. Harinarayan C.V., Arvind S., Joshi S., Thennarasu K., Vedavyas V., Baindur A. Improvement in pancreatic beta cell function with Vitamin D and calcium supplementation in vitamin D deficient non-diabetic subjects. Endocr Pract 2013, 1-33. [Epub ahead of print].
20. Mitri J., Dawson-Hughes B., Hu F.B., Pittas A.G. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and Vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011, 94:486-494.
21. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30:980-986.
22. Sergeev I.N., Rhoten W.B. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology 1995, 136:2852-2861.
23. Maestro B., Molero S., Bajo S., Davila N., Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct 2002, 20:227-232.
24. Michaelsson K., Melhus H., Warensjo Lemming E., Wolk A., Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013, 346:f228. 10.1136/bmj.f228.
25. Kaluza J., Orsini N., Levitan E.B., Brzozowska A., Roszkowski W., Wolk A. Dietary calcium and magnesium intake and mortality: a prospective study of men. Am J Epidemiol 2010, 171:801-807.
26. Booth A., Camacho P.A. Closer look at calcium absorption and the benefits and risks of dietary versus supplemental calcium. Postgrad Med 2013, 125:73-81.
27. Asemi Z., Tabassi Z., Heidarzadeh Z., Khorammian H., Sabihi S.S., Samimi M. Effect of calcium-vitamin D supplementation on metabolic profiles in pregnant women at risk for pre-eclampsia: a randomized placebo-controlled trial. Pak J Biol Sci 2012, 15:316-324.
28. Major G.C., Alarie F., Dore J., Phouttama S., Tremblay A. Supplementation with calcium+ vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007, 85:54-59.
29. Reid I.R. Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 2004, 21:7-17.
30. Cho H.J., Kang H.C., Choi S.A., Ju Y.C., Lee H.S., Park H.J. The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 2005, 28:1418-1423.